United States (US) Shingles Vaccine Market (2025-2031) | Size & Revenue, Industry, Companies, Competitive Landscape, Value, Segmentation, Trends, Share, Growth, Outlook, Forecast, Analysis

Market Forecast By Product (Shingrix, Zostavax, SKYZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine) And Competitive Landscape
Product Code: ETC9976125 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Shingles Vaccine Market Outlook
  • Market Size of United States (US) Shingles Vaccine Market, 2024
  • Forecast of United States (US) Shingles Vaccine Market, 2031
  • Historical Data and Forecast of United States (US) Shingles Vaccine Revenues & Volume for the Period 2021- 2031
  • United States (US) Shingles Vaccine Market Trend Evolution
  • United States (US) Shingles Vaccine Market Drivers and Challenges
  • United States (US) Shingles Vaccine Price Trends
  • United States (US) Shingles Vaccine Porter's Five Forces
  • United States (US) Shingles Vaccine Industry Life Cycle
  • Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Shingrix for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Zostavax for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By SKYZoster for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Vaccine Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Recombinant Vaccine for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Shingles Vaccine Market Revenues & Volume By Live Attenuated Vaccine for the Period 2021- 2031
  • United States (US) Shingles Vaccine Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Vaccine Type
  • United States (US) Shingles Vaccine Top Companies Market Share
  • United States (US) Shingles Vaccine Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Shingles Vaccine Company Profiles
  • United States (US) Shingles Vaccine Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Shingles Vaccine Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Shingles Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Shingles Vaccine Market - Industry Life Cycle

3.4 United States (US) Shingles Vaccine Market - Porter's Five Forces

3.5 United States (US) Shingles Vaccine Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Shingles Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F

4 United States (US) Shingles Vaccine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Shingles Vaccine Market Trends

6 United States (US) Shingles Vaccine Market, By Types

6.1 United States (US) Shingles Vaccine Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Shingles Vaccine Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Shingles Vaccine Market Revenues & Volume, By Shingrix, 2021- 2031F

6.1.4 United States (US) Shingles Vaccine Market Revenues & Volume, By Zostavax, 2021- 2031F

6.1.5 United States (US) Shingles Vaccine Market Revenues & Volume, By SKYZoster, 2021- 2031F

6.2 United States (US) Shingles Vaccine Market, By Vaccine Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Shingles Vaccine Market Revenues & Volume, By Recombinant Vaccine, 2021- 2031F

6.2.3 United States (US) Shingles Vaccine Market Revenues & Volume, By Live Attenuated Vaccine, 2021- 2031F

7 United States (US) Shingles Vaccine Market Import-Export Trade Statistics

7.1 United States (US) Shingles Vaccine Market Export to Major Countries

7.2 United States (US) Shingles Vaccine Market Imports from Major Countries

8 United States (US) Shingles Vaccine Market Key Performance Indicators

9 United States (US) Shingles Vaccine Market - Opportunity Assessment

9.1 United States (US) Shingles Vaccine Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Shingles Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F

10 United States (US) Shingles Vaccine Market - Competitive Landscape

10.1 United States (US) Shingles Vaccine Market Revenue Share, By Companies, 2024

10.2 United States (US) Shingles Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All